Supply Chain Pulse — 2026-07-10

CMS dropped its CY2027 OPPS proposed rule yesterday, and the headline number — a 2.4% outpatient payment bump — buries the sharper sting: significant cuts to 340B pharmaceutical reimbursements that could materially squeeze drug procurement budgets at safety-net and disproportionate-share hospitals. Layer on a federal initiative to rebuild crisis-ready domestic manufacturing capacity and UPS committing $48 million to temperature-controlled infrastructure, and today's stories sketch a clear throughline: payers, logistics players, and the government are all reshaping the environment your supply chain operates in, simultaneously. If your CFO hasn't flagged the 340B exposure yet, this is your morning to start that conversation — comments on the proposed rule are due before it finalizes.

Quick Hits

• CMS released the full CY2027 OPPS/ASC proposed rule (CMS-1850-P) — full text now available on the CMS newsroom for teams doing a deep-dive beyond the headline numbers. (CMS Newsroom)
• The global medical device reprocessing market is projected to grow at ~8% CAGR through 2034 — a tailwind for supply chains leaning on reprocessing programs to offset device cost pressure. (GDELT - Healthcare Supply Chain)

CMS Proposes 2.4% Hospital Outpatient Pay Bump — With a 340B Sting in the Fine Print

The CY2027 OPPS proposed rule offers a modest 2.4% payment increase for hospital outpatient services and ASCs, but the more consequential provision is a significant proposed cut to drug reimbursements under the 340B Drug Pricing Program. For supply chain leaders at 340B-eligible hospitals, this directly threatens one of the primary levers used to offset pharmaceutical acquisition costs — now is the time to model the impact and engage your GPO and pharmacy leadership before the comment window closes.

Source: Modern Healthcare

Innovating Healthcare Resilience: The U.S. Digital Stockpile Challenge

A federal competition is underway to build a secure, distributed network of manufacturers and digital repositories capable of rapidly producing essential healthcare products during crises — think on-demand surge capacity backed by pre-qualified suppliers and digital manufacturing files. For supply chain professionals still haunted by PPE and drug shortages from 2020–2022, this initiative represents a structural attempt to bake resilience into the national supply base rather than rely on strategic reserves alone. Watch this space: vendors and health systems that engage early with the program could gain preferred-partner positioning when the next disruption hits.

Source: Healthcare Purchasing News

UPS Announces $48 Million Investment in Temperature-Controlled Facilities

UPS is deploying $48 million to expand temperature-controlled infrastructure designed for short-term storage at the handoff between air and ground transport — a critical and historically vulnerable link in the cold chain for biologics, vaccines, and specialty pharmaceuticals. The investment signals that major carriers see sustained demand growth in healthcare logistics and are competing to own the compliance-sensitive middle mile. For supply chain teams managing specialty drug or cell-and-gene therapy distribution, this is worth a conversation with your logistics partners about whether new capacity translates to better SLA commitments.

Source: Healthcare Purchasing News

FedEx Launches Dedicated Life Sciences Unit to Integrate Healthcare Logistics

FedEx has formalized a dedicated life sciences business unit, consolidating its healthcare logistics capabilities under a single operating structure aimed at serving pharmaceutical, biotech, and medical device shippers. The move mirrors UPS's sustained push into healthcare-specific logistics and signals that both carriers are betting that complex, compliance-driven healthcare shipments are a durable growth market worth specializing in. For procurement teams, increased carrier competition in this space could mean more negotiating leverage — and higher service expectations you should be putting into your next RFP.

Source: GDELT - Healthcare Supply Chain

You're receiving this because you subscribed to Supply Chain Pulse, a daily brief for healthcare supply chain professionals. Unsubscribe